Characteristics of Chemotherapy-induced Neuropathy: Clinical Studies on Cisplatin and Docetaxel
(Kenmerken van door chemotherapie veroorzaakte polyneuropathie: klinische studies naar Cisplatin en Docetaxel)
View PDF Version
(980617_HILKENS, Pieter Hendrik Emmanuel.pdf, 3.5MB)
View PDF Version
(Stellingen HILKENS.pdf, 0.0MB)
Peripheral neurotoxicity is an important side-effect of several chemotherapeutic agents. These agents may cause a usually axonal neuropathy, which may ultimately lead to severe and disabling symptoms and signs. Besides describing in this review the pathogenesis, the clinical presentation, the neurophysiological findings and the nerve biopsies, we also recount the relation between cumulative dosage/dosage per cycle and neuropathy for the cytostatic drugs for which neurotoxicity is an important side-effect: cisplatin, vincristine, paclitaxel, docetaxel and suramin. With the development of strategies to circumvent toxicities of other organs and \\vith the use of combinations of neurotoxic agents such as cisplatinlpaclitaxel, neurotoxicity is an important and dose limiting side-effect of many treatment regimens. Detailed knowledge of the neurologic side-effects of these drugs is essential for the management of their neurotoxicity. The review concludes with a short discussion of neuro-protective agents. Although several nerve growth factors, gluthation and ethiofos hold promise as possible neuroprotective factors, the clinical data on these drugs are still limited. New trials are needed to confirm the value of these drugs. If neurotoxicity can indeed be prevented or delayed, this may lead to more effective treatment regimens.
De uitgave van dit proefschrift is mede mogelijk gemaakt door financiele ondersteuning van Merck
Sharp & Dohme, Novartis Pharma, Ipsen Phannaceutica, Eli Lily, Schering, Biogen, Glaxo Wellcome,
ASla Medica, Rh()ne Poulenc Rorer, Katwijk Fanna, Yamanouchi Phanna, Sanofi Winthrop en de
dr Eduard Haelen Stichting te Wassenaar.
- cisplatin neuropathy